IP Library Granted Patent US 11,479,877
Granted Patent B2
US 11,479,877 · App. 16/748,441 · Granted Oct 25, 2022

Display library process

Inventors: Robert Charles Ladner (Ijamsville, MD); Shannon Hogan (Arlington, MA); Kristin L. Rookey (Lebanon, NH)
Assignee: Takeda Pharmaceutical Company Limited
C40B30/04B03C1/01B03C1/288C12N15/1037G01N33/56983G01N2500/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,479,877
App. No.
16/748,441
Granted
Oct 25, 2022
Kind
B2
Abstract

Disclosed are methods for identifying desired members from a display libraries, including bacteriophage display libraries. Display library members can be amplified in the presence of a target compound so that cycles of selection can be rapidly completed.

Claims (12)

1. A method of selecting phage that encode a target binding protein from a plurality of phage particles, the method comprising:

a) contacting a plurality of diverse phage particles with a first target to form phage-target complexes, wherein each phage of the plurality displays a heterologous protein component on its surface and each phage includes a nucleic acid encoding the heterologous protein component, and wherein each phage-target complex comprises a phage from the plurality, the heterologous protein displayed on which binds the first target;

b) separating the phage-target complexes from unbound phage particles;

c) contacting host cells with the separated phage-target complexes in a suitable growth medium so that the host cells are infected by the phage particles of the phage-target complexes to yield a first population of infected cells;

d) incubating the first population of infected cells in the presence of a second target under conditions allowing for replication of the phage particles, thereby forming phage-target complexes that include replicate phage particles that bind to the second target;

e) separating replicate phage particles that do not bind to the second target from the replicate phage-target complexes; and

f) contacting host cells with the replicate phage target complexes so that host cells are infected with the replicate phage particles of the complexes to yield a second population of infected cells, wherein the second population of infected cells produce phage particles that encode heterologous proteins binding to both the first target and the second target;

wherein the first target and the second target are different.

2. The method of claim 1 , wherein the first target is immobilized to a support prior to step (a).

3. The method of claim 1 , wherein the first target is immobilized to a support during step (a).

4. The method of claim 1 , wherein the second target is immobilized to a support prior to step (d).

5. The method of claim 1 , wherein the second target is immobilized during step (d).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2021
From: LADNER, ROBERT C.; HOGAN, SHANNON; ROOKEY, KRISTIN
To: DYAX CORP.
Reel/Frame 058057/0304 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2021
From: DYAX CORP.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056268/0983 →